Is it Finally Time to Buy Medical Properties Trust?
Medical Properties Trust (NYSE:MPW) is a REIT that focuses on…
Buy
69
HURN Quote, Financials, Valuation and Earnings
Last price:
$142.32
Seasonality move
:
6.03%
Day range:
$140.82 - $144.44
52-week range:
$84.26 - $153.85
Dividend yield:
0%
P/E ratio:
22.69x
P/S ratio:
1.74x
P/B ratio:
4.49x
Volume:
218.2K
Avg. volume:
246.5K
1-year change:
48.16%
Market cap:
$2.5B
Revenue:
$1.5B
EPS (TTM):
$6.29
Analysts' Opinion
-
Consensus RatingHuron Consulting Group has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $169.25, Huron Consulting Group has an estimated upside of 18.6% from its current price of $142.71.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $165.00 representing -15.62% downside risk from its current price of $142.71.
Fair Value
-
According to the consensus of 4 analysts, Huron Consulting Group has 18.6% upside to fair value with a price target of $169.25 per share.
HURN vs. S&P 500
-
Over the past 5 trading days, Huron Consulting Group has underperformed the S&P 500 by -4.37% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Huron Consulting Group does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Huron Consulting Group has grown year-over-year revenues for 15 quarters straight. In the most recent quarter Huron Consulting Group reported revenues of $399.3M.
Earnings Growth
-
Huron Consulting Group has grown year-over-year earnings for 4 quarters straight. In the most recent quarter Huron Consulting Group reported earnings per share of $1.84.
Enterprise value:
2.9B
EV / Invested capital:
3.11x
Price / LTM sales:
1.74x
EV / EBIT:
15.99x
EV / Revenue:
1.88x
PEG ratio (5yr expected):
0.24x
EV / Free cash flow:
16.93x
Price / Operating cash flow:
15.71x
Enterprise value / EBITDA:
14.01x
Gross Profit (TTM):
$476M
Return On Assets:
8.83%
Net Income Margin (TTM):
7.66%
Return On Equity:
22.32%
Return On Invested Capital:
12.1%
Operating Margin:
12.38%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $1.2B | $1.4B | $1.5B | $350M | $399.3M | |
| Gross Profit | $346.4M | $419.3M | $476M | $105.1M | $128.4M | |
| Operating Income | $109.7M | $136.9M | $178.7M | $32M | $49.4M | |
| EBITDA | $137M | $161.8M | $204M | $38.3M | $56.4M | |
| Diluted EPS | $3.64 | $3.20 | $6.29 | $0.15 | $1.84 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $230.5M | $257.7M | $328.5M | $400.5M | $409.1M | |
| Total Assets | $1.1B | $1.1B | $1.2B | $1.3B | $1.3B | |
| Current Liabilities | $186.9M | $205.2M | $245.7M | $302.6M | $338.8M | |
| Total Liabilities | $499M | $547.4M | $647M | $729.3M | $782.3M | |
| Total Equity | $551.9M | $571.9M | $552M | $532.9M | $561.3M | |
| Total Debt | $203.3M | $232.8M | $290M | $324M | $356.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $85.4M | $135.3M | $201.3M | $80.4M | $139.6M | |
| Cash From Investing | -$20.1M | -$36.7M | -$79.7M | -$10.9M | -$31.7M | |
| Cash From Financing | -$74.1M | -$98.3M | -$111.6M | -$66.8M | -$104.3M | |
| Free Cash Flow | $61.1M | $100.1M | $168.7M | $69.9M | $132.4M | |
HURN
Sector
Market Cap
$2.5B
$618.1M
Price % of 52-Week High
92.76%
74.85%
Dividend Yield
0%
0%
Shareholder Yield
6.6%
2.42%
1-Year Price Total Return
48.16%
-6%
Beta (5-Year)
0.531
0.886
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$145.08
200-day SMA
Buy
Level
$116.75
Bollinger Bands (100)
Buy
Level
118.93 - 138.87
Chaikin Money Flow
Buy
Level
42M
20-day SMA
Sell
Level
$146.60
Relative Strength Index (RSI14)
Buy
Level
51.09
ADX Line
Buy
Level
25.75
Williams %R
Neutral
Level
-74.9543
50-day SMA
Buy
Level
$135.47
MACD (12, 26)
Buy
Level
2.35
25-day Aroon Oscillator
Buy
Level
20
On Balance Volume
Neutral
Level
54.8M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.8767)
Buy
CA Score
(Annual)
Level (0.2445)
Buy
Beneish M-Score
(Annual)
Level (-2.6131)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (0.1556)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Huron Consulting Group Inc is a professional services firm. The company provides expertise in technology, operations, advisory services, & analytics through three operating segments namely Healthcare, Education, and Commercial. Healthcare segment helps the firms to transform and innovate the delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health, Education segment provides management consulting and technology solutions, and Commercial segment is focused on serving industries and organizations facing disruption and regulatory change. It generates a majority of its revenue from the Healthcare Segment.
Stock Forecast FAQ
In the current month, HURN has received 4 Buy ratings 0 Hold ratings, and 0 Sell ratings. The HURN average analyst price target in the past 3 months is $169.25.
-
Where Will Huron Consulting Group Stock Be In 1 Year?
According to analysts, the consensus estimate is that Huron Consulting Group share price will rise to $169.25 per share over the next 12 months.
-
What Do Analysts Say About Huron Consulting Group?
Analysts are divided on their view about Huron Consulting Group share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Huron Consulting Group is a Sell and believe this share price will drop from its current level to $165.00.
-
What Is Huron Consulting Group's Price Target?
The price target for Huron Consulting Group over the next 1-year time period is forecast to be $169.25 according to 4 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is HURN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Huron Consulting Group is a Buy. 4 of 4 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of HURN?
You can purchase shares of Huron Consulting Group via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Huron Consulting Group shares.
-
What Is The Huron Consulting Group Share Price Today?
Huron Consulting Group was last trading at $142.32 per share. This represents the most recent stock quote for Huron Consulting Group. Yesterday, Huron Consulting Group closed at $142.71 per share.
-
How To Buy Huron Consulting Group Stock Online?
In order to purchase Huron Consulting Group stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Signet Jewelers Stock Go Up So Much?
Signet Jewelers (NYSE:SIG) is the largest diamond retailer in the…
Why Did HealthEquity Stock Fall So Much?
HealthEquity (NASDAQ:HQY) is a fintech company that acts as an…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
44
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
69
CNXC alert for Mar 28
Concentrix [CNXC] is down 12.39% over the past day.
Buy
74
SLNO alert for Mar 28
Soleno Therapeutics [SLNO] is up 6.8% over the past day.
Buy
51
CAR alert for Mar 28
Avis Budget Group [CAR] is up 0.71% over the past day.
